Clinuvel Pharmaceuticals
CUV.AX
#6867
Rank
NZ$0.74 B
Marketcap
$14.91
Share price
-1.17%
Change (1 day)
-12.61%
Change (1 year)

EPS for Clinuvel Pharmaceuticals (CUV.AX)

EPS in 2023: $0.70

According to Clinuvel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.70. In 2023 the company made an earnings per share (EPS) of $0.70 an increase over its 2022 EPS that were of $0.50.

EPS history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023$0.7040.79%
2022$0.50-22.53%
2021$0.6461.74%
2020$0.40-12.03%
2019$0.4528.75%
2018$0.3579.08%
2017$0.20-318.99%
2016-$0.08909-71.6%
2015-$0.3136.75%
2014-$0.23-23.66%
2013-$0.30-45.84%
2012-$0.55-18.99%
2011-$0.6825.76%
2010-$0.54-22.24%
2009-$0.70-10.59%
2008-$0.7846.78%
2007-$0.53-34.2%
2006-$0.81-25.89%
2005-$1.0940.91%
2004-$0.7855.12%
2003-$0.5052.02%
2002-$0.3371.69%
2001-$0.19355.46%
2000-$0.04212